Literature DB >> 9580582

The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys.

N K Mello1, S S Negus.   

Abstract

Concurrent abuse of cocaine and opioids is frequently observed clinically, and we have developed a model of "speedball" self-administration involving the simultaneous injection of cocaine and heroin combinations in rhesus monkeys (Mello et al. (1995) J Pharmacol Exp Ther 274:1325). In the present study, we evaluated the effects of buprenorphine (0.0075-0.75 mg/kg/day i.v.) and saline on speedball combinations of cocaine [0.001, 0.01 or 0.10 mg/kg/inj] and heroin [0.0001-0.032 mg/kg/inj]. We also examined the effects of buprenorphine (0.075 and 0.237 mg/kg/day i.v.) on self-administration of heroin alone (0.0001-0.01 mg/kg/inj). Drug and food (1-g banana pellets) self-administration were maintained on a second-order FR4 (VR16:S) schedule in four 1-hr sessions each day. Each buprenorphine or saline control treatment was evaluated for 10 consecutive days, and monkeys returned to base-line performance between each treatment condition. Buprenorphine (0.075-0.75 mg/kg/day) selectively reduced self-administration of speedball combinations of low-dose cocaine (0.001 mg/kg/inj) and heroin (0.001 or 0.0032 mg/kg/inj) (P < .05-.01), and buprenorphine (0.237 mg/kg/day) shifted dose-effect curves for speedball combinations of cocaine (0.001 mg/kg/inj) and heroin (0.0001-0.032 mg/kg/inj) downward (P < .05-.01) and approximately 1 log unit to the right. Buprenorphine treatment was less effective in decreasing responding maintained by speedball combinations of heroin and 0.01 and 0.10 mg/kg/inj cocaine. Buprenorphine treatment (0.075 and 0.237 mg/kg/day) also shifted the heroin dose-effect curve downward (P < .01-.001) and to the right. Both speedball and heroin self-administration were associated with dose-dependent decreases in food-maintained responding during saline control treatment. However, food-maintained responding was often higher than control levels during buprenorphine treatment (P < .05-.001), which suggests that buprenorphine antagonized the rate-decreasing effects of speedballs and of heroin. Buprenorphine's selective reduction of speedball and heroin self-administration is consistent with clinical treatment trials in opioid abusers and polydrug abusers. Thus, these primate models of speedball and heroin self-administration should be useful for preclinical evaluation of novel drug abuse treatment medications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580582

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

Review 1.  Recent advances in the biology of addiction.

Authors:  S E Hemby
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES.

Authors:  N K Mello
Journal:  NIDA Res Monogr       Date:  2005-05

3.  Models of neurological disease (substance abuse): self-administration in monkeys.

Authors:  Donna M Platt; Galen Carey; Roger D Spealman
Journal:  Curr Protoc Pharmacol       Date:  2011-12

4.  Discriminative and reinforcing stimulus effects of nicotine, cocaine, and cocaine + nicotine combinations in rhesus monkeys.

Authors:  Nancy K Mello; Jennifer L Newman
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

5.  Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.

Authors:  Sarah L Withey; Roger D Spealman; Jack Bergman; Carol A Paronis
Journal:  J Pharmacol Exp Ther       Date:  2019-08-14       Impact factor: 4.030

6.  Self administration of cocaine in monkeys receiving LAAM acutely or chronically.

Authors:  Lisa R Gerak; Ruggero Galici; Charles P France
Journal:  Physiol Behav       Date:  2007-07-28

Review 7.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

Review 8.  Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.

Authors:  Mark K Greenwald; Sandra D Comer; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2014-08-19       Impact factor: 4.492

9.  Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.

Authors:  Cindy Achat-Mendes; Glenn R Valdez; Donna M Platt; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2009-02-19       Impact factor: 4.530

10.  Effects of chronic buprenorphine treatment on levels of nucleus accumbens glutamate and on the expression of cocaine-induced behavioral sensitization in rats.

Authors:  F M Placenza; H Rajabi; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  2008-07-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.